Given that mouse cells have 50-fold lower DNA-PKcs protein levels than their human counterparts40, this might explain why we did not see any DNA-PK-mediated compensatory phosphorylation of CHK111 as reported in human cancer cells treated with ATR inhibitor. Here, PRKDC is linked to cancer.